There are currently 1290 clinical trials in Miami, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Miami, GSK Investigational Site, University of Miami Miller School of Medicine-Sylvester Cancer Center and University of Miami Miller School of Medicine. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)
NCT05308264
Recruiting
Phase 1b Study of R289 in Participants with Lower-risk Myelodysplastic Syndromes (LR MDS)
Gender:
All
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: University of Miami, Miami, Florida
Conditions: Low Risk Myelodysplastic Syndromes
Register for Updates
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
NCT06080438
Recruiting
The purpose of this research study is to test if Topical (applied to the surface of the eye) Botulinum Toxin temporarily lowers the upper eyelid and makes the eyelid appear less open and thereby affects the eye surface and decreases reflexive tearing.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: University of Miami, Miami, Florida
Conditions: Tears; Excess, Eyelid Spasm
Register for Updates
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
NCT04759664
Recruiting
The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorectal cancer (mCRC) patients who developed Grade 2 or non-infected Grade 3 EGFRI induced acneiform lesions
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2023
Locations: Miami Dermatology & Laser Research, Miami, Florida +1 locations
Conditions: EGFRI Induced Acneiform Lesions
Register for Updates
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
NCT04892472
Recruiting
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System with IV pembrolizumab in subjects previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the progression-free survival (PFS) by RECIST 1.1 in subjects with TPS ≥1 percent, 1L metastatic/current advanced NSCLC treated with TTFields concomitant with pembrolizumab compared to t... Read More
Gender:
All
Ages:
22 years and above
Trial Updated:
10/04/2023
Locations: Miami Cancer Insititute - Baptist Health South Florida, Miami, Florida
Conditions: Non-small Cell Lung Cancer
Register for Updates
CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology
NCT02577302
Recruiting
This is a prospective, randomized, controlled, multi-center, study in which 150 evaluable subjects will be randomized 1:1 to receive either a Protect CAN-Stim or SNS InterStim® system. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/03/2023
Locations: Baptist Health Miami Cancer Institute, Miami, Florida
Conditions: Urinary Incontinence, Urge
Register for Updates
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)
NCT04636801
Recruiting
The purpose of the study is to evaluate the efficacy and safety of two doses of CHF6001 (Tanimilast), as add-on to maintenance triple therapy in the target patient population.
Gender:
All
Ages:
40 years and above
Trial Updated:
10/02/2023
Locations: Chiesi Clinical Trial - Site 840407, Miami, Florida +3 locations
Conditions: Chronic Obstructive Pulmonary Disease
Register for Updates
Citadel Embolization Device Study
NCT04057352
Recruiting
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/29/2023
Locations: University of Miami/Jackson Memorial, Miami, Florida
Conditions: Unruptured Wide-neck Aneurysms
Register for Updates
Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
NCT04539236
Recruiting
The purpose of this study is to evaluate if the combination of drugs, Lenalidomide and Luspatercept, will help improve the treatment of anemia in patients with lower-risk Myelodysplastic Syndrome (MDS).
Gender:
All
Ages:
18 years and above
Trial Updated:
09/29/2023
Locations: University of Miami, Miami, Florida
Conditions: Myelodysplastic Syndromes
Register for Updates
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
NCT05412082
Recruiting
The purpose of this research study is to find out how safe and effective is treating patients with locally advanced rectal cancer (LARC) with chemotherapy first and then follow with radiation therapy to a higher dose than what is usually delivered and see if patients could have complete response and be spared from surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2023
Locations: University of Miami, Miami, Florida
Conditions: Locally Advanced Rectal Cancer
Register for Updates
Post-Approval Study of the TREO Abdominal Stent-Graft System
NCT04697784
Recruiting
The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/27/2023
Locations: Mount Sinai Medical Center, Miami, Florida
Conditions: Abdominal Aortic Aneurysm
Register for Updates
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
NCT05812924
Recruiting
The purpose of this study is to determine whether platelet rich plasma (PRP) injections to the vulva and vagina will improve symptoms of genitourinary syndrome of menopause (GSM) in breast cancer patients.
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/27/2023
Locations: University of Miami, Miami, Florida
Conditions: Breast Cancer, Genitourinary Syndrome of Menopause
Register for Updates
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
NCT04650256
Recruiting
The purpose of this research is to study a Chinese herbal Complementary and Alternative Medicine (CAM) product for the temporary relief of pain and itching after radiotherapy (RT). This is an over-the-counter product with 1% menthol as an active ingredient.
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/26/2023
Locations: University of Miami, Miami, Florida
Conditions: Skin Toxicity
Register for Updates